The journey of patients with diffuse large B-cell lymphoma: from symptoms to diagnosis

被引:0
作者
Vodicka, Prokop [1 ,2 ]
Masar, Michal [1 ,2 ]
Benesova, Katerina [1 ,2 ]
Koren, Jan [1 ,2 ]
Klener, Pavel [1 ,2 ]
Polgarova, Kamila [1 ,2 ]
Galko, Jan [3 ]
Jaksa, Radek [3 ]
Campr, Vit [2 ,4 ,5 ]
Dlouha, Jitka [1 ,2 ,6 ]
Hrabetova, Sarka [1 ,2 ,6 ]
Blahovcova, Petra [1 ,2 ,6 ]
Klanova, Magdalena [1 ,2 ]
Trneny, Marek [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Med 1, U Nemocnice 499-2, Prague 2, Czech Republic
[2] Gen Hosp, U Nemocnice 499-2, Prague 2, Czech Republic
[3] Charles Univ Prague, Inst Pathol, Fac Med 1, Prague, Czech Republic
[4] Charles Univ Prague, Dept Pathol & Mol Med, Fac Med 2, Prague, Czech Republic
[5] Motol Univ Hosp, Prague, Czech Republic
[6] Czech Lymphoma Study Grp, Datactr, Prague, Czech Republic
关键词
Non-Hodgkin lymphoma; extranodal lymphoma; diffuse large B-cell lymphoma; symptoms; time to diagnosis;
D O I
10.1080/10428194.2025.2475327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Symptoms of lymphomas include peripheral lymphadenopathy, B-symptoms, and other organ-specific symptoms; however, data on initial symptoms incidence in diffuse large B-cell lymphoma (DLBCL) remain limited. We aimed to investigate real-world patterns of initial DLBCL symptoms, correlating them with baseline characteristics and symptom onset-to-diagnosis interval. Patients with DLBCL diagnosed between 2010 and 2021 receiving R-CHOP were screened. 706 individuals with reported initial symptoms were analyzed. 682 (97%) patients had documented symptoms; remaining 24 patients (3%) had incidental findings discovered during examinations for unrelated reasons. Abdominal/gastrointestinal complaints were the most prevalent symptoms (26%), followed by peripheral lymphadenopathy (22%), and B-symptoms (13%). The median symptom-to-diagnosis interval was 10 weeks. Peripheral lymphadenopathy and testicular tumors correlated with low-risk characteristics, with testicular DLBCL featuring a shorter symptom-to-diagnosis interval. Limb pain/swelling and back pain were associated with high-risk characteristics and prolonged symptom-to-diagnosis interval. This analysis enhances our understanding of DLBCL symptomatology, aiding in timely recognition and management.
引用
收藏
页码:1293 / 1299
页数:7
相关论文
共 16 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: An analysis of the Surveillance, Epidemiology and End Results database [J].
Castillo, Jorge J. ;
Winer, Eric S. ;
Olszewski, Adam J. .
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (03) :310-314
[3]   Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes [J].
Chapuy, Bjoern ;
Stewart, Chip ;
Dunford, Andrew J. ;
Kim, Jaegil ;
Kamburov, Atanas ;
Redd, Robert A. ;
Lawrence, Mike S. ;
Roemer, Margaretha G. M. ;
Li, Amy J. ;
Ziepert, Marita ;
Staiger, Annette M. ;
Wala, Jeremiah A. ;
Ducar, Matthew D. ;
Leshchiner, Ignaty ;
Rheinbay, Ester ;
Taylor-Weiner, Amaro ;
Coughlin, Caroline A. ;
Hess, Julian M. ;
Pedamallu, Chandra S. ;
Livitz, Dimitri ;
Rosebrock, Daniel ;
Rosenberg, Mara ;
Tracy, Adam A. ;
Horn, Heike ;
van Hummelen, Paul ;
Feldman, Andrew L. ;
Link, Brian K. ;
Novak, Anne J. ;
Cerhan, James R. ;
Habermann, Thomas M. ;
Siebert, Reiner ;
Rosenwald, Andreas ;
Thorner, Aaron R. ;
Meyerson, Matthew L. ;
Golub, Todd R. ;
Beroukhim, Rameen ;
Wulf, Gerald G. ;
Ott, German ;
Rodig, Scott J. ;
Monti, Stefano ;
Neuberg, Donna S. ;
Loeffler, Markus ;
Pfreundschuh, Michael ;
Truemper, Lorenz ;
Getz, Gad ;
Shipp, Margaret A. .
NATURE MEDICINE, 2018, 24 (05) :679-+
[4]   Diffuse large B-cell lymphoma [J].
Li, Shaoying ;
Young, Ken H. ;
Medeiros, L. Jeffrey .
PATHOLOGY, 2018, 50 (01) :74-87
[5]   Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment [J].
Liu, Yang ;
Barta, Stefan Klaus .
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (05) :604-616
[6]   Diffuse large B-cell lymphoma:: Clinical and biological characterization and outcome according to the nodal or extranodal primary origin [J].
López-Guillermo, A ;
Colomo, L ;
Jiménez, M ;
Bosch, F ;
Villamor, N ;
Arenillas, L ;
Muntañola, A ;
Montoto, S ;
Giné, E ;
Colomer, D ;
Beà, S ;
Campo, E ;
Montserrat, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2797-2804
[7]   Diffuse large B-cell lymphoma [J].
Martelli, Maurizio ;
Ferreri, Andres J. M. ;
Agostinelli, Claudio ;
Di Rocco, Alice ;
Pfreundschuh, Michael ;
Pileri, Stefano A. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) :146-171
[8]   Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials [J].
Maurer, Matthew J. ;
Ghesquieres, Herve ;
Link, Brian K. ;
Jais, Jean-Philippe ;
Habermann, Thomas M. ;
Thompson, Carrie A. ;
Haioun, Corinne ;
Allmer, Cristine ;
Johnston, Patrick B. ;
Delarue, Richard ;
Micallef, Ivana N. ;
Peyrade, Frederic ;
Inwards, David J. ;
Ketterer, Nicolas ;
Farooq, Umar ;
Fitoussi, Olivier ;
Macon, William R. ;
Molina, Thierry J. ;
Syrbu, Sergei ;
Feldman, Andrew L. ;
Slager, Susan L. ;
Weiner, George J. ;
Ansell, Stephen M. ;
Cerhan, James R. ;
Salles, Gilles A. ;
Witzig, Thomas E. ;
Tilly, Herve ;
Nowakowski, Grzegorz S. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (16) :1603-+
[9]   TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
OKEN, MM ;
CREECH, RH ;
TORMEY, DC ;
HORTON, J ;
DAVIS, TE ;
MCFADDEN, ET ;
CARBONE, PP .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655
[10]   Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence [J].
Ollila, Thomas A. ;
Olszewski, Adam J. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)